BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
Welcome,         Profile    Billing    Logout  
 9 Trials 
14 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Illmer, Thomas
COMPASS, NCT03164980: Comparison of QoL Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Completed
4
89
Europe
Trabectidin (Yondelis)
North Eastern German Society of Gynaecological Oncology, Frankfurter Institut für Klinische Krebsforschung IKF GmbH, PharmaMar
Quality of Life, Ovarian Cancer, Recurrent Ovarian Carcinoma
08/23
08/23
CLL17, NCT04608318 / 2019-003854-99: Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

Active, not recruiting
3
897
Europe, RoW
Ibrutinib, Imbruvica, Venetoclax, ABT-199, Venclyxto, Obinutuzumab, GA101, Gazyvaro
German CLL Study Group, Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Nordic CLL Study Group (NCLLSG), Swiss Group for Clinical Cancer Research (SAKK), Cancer Trials Ireland, Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA), Grupo Español de Leucemia Linfocítica Crónica (GELLC), The Israeli CLL Study Group (ICLLSG)
Chronic Lymphoid Leukemia
03/27
03/27
ARCHED, NCT05820841: Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma

Recruiting
3
330
Europe
R-miniCHOP + Acalabrutinib, R-miniCHOP
Universität des Saarlandes, University of Leipzig, University Hospital Regensburg, Wuerzburg University Hospital, University Hospital of Gießen and Marburg, Saarland University Medical Center, AstraZeneca
Large B-cell Lymphoma, Diffuse Large B Cell Lymphoma
04/28
12/28
Keynote-717, NCT03386357 / 2017-002122-20: Radiotherapy With Pembrolizumab in Metastatic HNSCC

Active, not recruiting
2
130
Europe
A (pembrolizumab+RT), Keytruda + RT, B (pembrolizumab), Keytruda
University of Erlangen-Nürnberg Medical School, Medical Faculty of the Friedrich-Alexander University Erlangen-Nürnberg
Head and Neck Squamous Cell Carcinoma
01/25
01/26
LUCAS, NCT05178342: Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes With CA-4948

Terminated
2
38
Europe
CA-4948, Emavusertib
University of Leipzig, Curis, Inc.
Myelodysplastic Syndromes, Anemia
07/24
07/24
NCT05433116: Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC

Recruiting
2
50
Europe
Pembrolizumab, Keytruda, Lenvatinib, Lenvima
Universität des Saarlandes
Head and Neck Squamous Cell Carcinoma
09/25
09/26
DREAMM 9, NCT04091126 / 2019-003047-30: Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma

Checkmark From DREAMM-9 trial for 1L transplant ineligible multiple myeloma at ASH 2021
Dec 2021 - Dec 2021: From DREAMM-9 trial for 1L transplant ineligible multiple myeloma at ASH 2021
Recruiting
1
144
Europe, Canada, US, RoW
Belantamab mafodotin, Bortezomib, Lenalidomide, Dexamethasone
GlaxoSmithKline
Multiple Myeloma
11/24
06/25
INFINITY, NCT04389541: Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology

Completed
N/A
499
Europe
iOMEDICO AG, Bristol-Myers Squibb, Roche Pharma AG
Advanced Solid Tumors or Hematologic Malignancies
06/23
06/23
DigiNet, NCT05818449: Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation

Active, not recruiting
N/A
850
Europe
DigiNet intervention
University of Cologne, Gemeinsamer Bundesausschuss (G-BA), AOK Rheinland/Hamburg, AOK Nordwest, BARMER, University Hospital, Essen, Charite University, Berlin, Germany, Berlin Institute of Health, Helios Klinikum Emil von Behring, University Hospital Carl Gustav Carus, Deutsche Krebsgesellschaft e.V., Berufsverband der Niedergelassenen Hämatologen und Onkologen in Deutschland e.V., AOK Bundesverband, FOM Hochschule für Oekonomie und Management, University Medicine Greifswald, Technische Universität Dresden
Non-small Cell Lung Cancer Stage IV
03/25
03/25
PRO-RED, NCT05582902: Study Investigating Patient-Reported Outcomes in Lower-risk MDS Patients

Recruiting
N/A
60
Europe
University of Leipzig, Deutsche Krebshilfe e.V., Bonn (Germany)
MDS, MDS/MPN
03/25
03/25
ITP-Registry, NCT05152238: ITP Registry and Accompanying Biospecimen Collection

Recruiting
N/A
1100
Europe
Jena University Hospital, University Hospital Dresden, Novartis, Swedish Orphan Biovitrum, Grifols Biologicals, LLC, Amgen, argenx
Immune Thrombocytopenia
09/26
04/27
NCT03125707: German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)

Recruiting
N/A
2172
Europe
Registry study
University of Ulm
BCR-ABL1-Negative Myeloid Neoplasms
09/45
09/45
Hallek, Michael
CLL-Registry, NCT02863692: Registry of the German CLL Study Group

Recruiting
N/A
8000
Europe
German CLL Study Group
CLL, SLL, HCL, Richter´s Transformation, Leukemia, Prolymphocytic, B-Cell, Leukemia, Prolymphocytic, T-Cell, T-LGL Leukemia, NK-LGL Leukemia
12/26
12/26
Jakobasch, Lutz
CLL-Registry, NCT02863692: Registry of the German CLL Study Group

Recruiting
N/A
8000
Europe
German CLL Study Group
CLL, SLL, HCL, Richter´s Transformation, Leukemia, Prolymphocytic, B-Cell, Leukemia, Prolymphocytic, T-Cell, T-LGL Leukemia, NK-LGL Leukemia
12/26
12/26

Download Options